Blood interleukin 10 levels parallel the severity of septic shock

Journal of Critical Care

Volumn 12, Issue 4, 1997, Pages 183-187

  Friedman, Gilberto ^a   Jankowski, Stanislaw ^a   Marchant, Arnaud ^a   Goldman, Michel ^a   Kahn, Robert Jean ^a   Vincent, Jean Louis ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CORRELATION FUNCTION; DISEASE SEVERITY; FEMALE; HUMAN; MALE; MULTIPLE ORGAN FAILURE; SEPTIC SHOCK;

EID: 0031445867     PISSN: 08839441     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0883-9441(97)90030-7     Document Type: Article

References (34)

1. Calandra T, Gerain J, Heumann D, et al: High circulating levels of interleukin-6 in patients with septic shock: Evolution during sepsis, prognostic value, and interplay with other cytokines. Am J Med 91:23-29, 1991
2. Pinsky MR, Vincent JL, Deviere J, et al: Serum cytokine levels in human septic shock: Relation to multiple-systems organ failure and mortality. Chest 103:565-575, 1993
3. Marty C, Misset B, Tamion F, et al: Circulating interleukin-8 concentrations in patients with multiple organ failure of septic and nonseptic origin. Crit Care Med 22:673-679, 1994
4. Gomez-Jimenez J, Martin MC, Sauri R, et al: Interleukin-10 and the monocyte/macrophage-induced inflammatory response in septic shock. J Infect Dis 171:472-475, 1995
5. van-der-Poll T, Jansen J, van-Leenen D, et al: Release of soluble receptors for tumor necrosis factor in clinical sepsis and experimental endotoxemia. J Infect Dis 168:955-960, 1993
6. Marchant A, Devière J, Byl B, et al: Interleukin-10 production during septicaemia. Lancet 344:707-708, 1994
7. de Waal Malefyt R, Abrahams J, Bennet B, et al: Interleukin-10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209-1220, 1991
8. Fiorentino DF, Zlotnik A, Mosmann TR, et al: IL-10 inhibits cytokine production by activated macrophages. J Immunol 147:3815-3822, 1991
9. Cunha FQ, Moncada S, Liew FY: Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-gamma in murine macrophages. Biochem Biophys Res Commun 182:1155-1159, 1992
10. Gérard C, Bruyns C, Marchant A, et al: Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med 177:547-550, 1993
11. Derkx B, Marchant A, Goldman M, et al: High levels of interleukin-10 during the initial phase of fulminant meningococcal septic shock. J Infect Dis 171:229-232, 1995
12. Marchant A, Bruyns C, Vandenabeele P, et al: Interleukin-10 controls interferon-y and tumor necrosis factor production during experimental endotoxemia. Eur J Immunol 24:1167-1171, 1994
13. Van Deventer SJ, Buller HR, ten Cate JW, et al: Experimental endotoxemia in humans: Analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood 76:2520-2526, 1990
14. von der Möhlen MAM, Kimmings AN, Wedel NI, et al: Inhibition of endotoxin-induced cytokine release and neutrophil activation in humans by use of recombinant bactericidal/ permeability-increasing protein. J Infect Dis 172:144-151, 1995
15. Lehmann AK, Halstensen A, Rokke O, et al: High levels of interleukin 10 in serum are associated with fatality in meningococcal disease. Infect Immun 63:2109-2112, 1995
16. Kornelisse RF, Savelkoul HFJ, Mulder PHG, et al: Interleukin-10 and soluble tumor necrosis factor receptors in cerebrospinal fluid of children with bacterial meningitis. J Infect Dis 173:1498-1502, 1996
17. Parsons PE, Moss M, Vannice JL, et al: Circulating IL-1ra and IL-10 levels are increased but do not predict the development of acute respiratory distress syndrome in at-risk patients. Am J Respir Crit Care Med 155:1469-1473, 1997
18. Tabardel Y, Duchateau J, Schmartz D, et al: Corticosteroids increase blood interleukin-10 levels during cardiopulmonary bypass in men. Surgery 119:76-80, 1996
19. Cassatella MA, Meda L, Bonora S, et al: Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes: Evidence for an autocrine role of tumor necrosis factor and IL-1b in mediating the production of IL-8 triggered by lipopolysaccharide. J Exp Med 178:2207-2211, 1993
20. Van der Poll T, Jansen PM, Montegut WJ, et al: Effects of IL-10 on systemic inflammatory responses during sublethal primate endotoxemia. J Immunol 158:1971-1975, 1997
21. Chernoff AE, Granowitz EV, Shapiro L, et al: A randomized, controlled trial of IL-10 in humans: Inhibition of inflammatory cytokine production and immune responses. J Immunol 154:5492-5499, 1995
22. Huhn RD, Radwanski E, O'Connell SM, et al: Pharmacokinetics and immunomodulatory properties of intravenously administered recombinant human interleukin-10 in healthy volunteers. Blood 87:699-705, 1996
23. Howard M, Muchamuel T, Andrade S, et al: Interleukin 10 protects mice from lethal endotoxemia. J Exp Med 177:1205-1208, 1993
24. Kusske AM, Rongione AJ, Ashley SW, et al: Interleukin-10 prevents death in lethal necrotizing pancreatitis in mice. Surgery 120:284-289, 1996
25. Van der Poll T, Marchant A, Buurman WA, et al: Endogenous IL-10 protects mice from death during septic peritonitis. J Immunol 155:5397-5401, 1995
26. Greenberger MJ, Strieter RM, Kunkel SL, et al: Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia. J Immunol 155:722-729, 1995
27. Ertel W, Keel M, Steckholzer U, et al: Interleukin-10 attenuates the release of proinflammatory cytokines but depresses splenocyte functions in murine endotoxemia. Arch Surg 131:51-56, 1996
28. Klava A, Windsor ACJ, Farmery SM, et al: Interleukin-10: A role in the development of postoperative immunosuppression. Arch Surg 132:425-429, 1997
29. Sprung CL, Schultz DR, Marcial E, et al: Complement activation in septic shock patients. Crit Care Med 14:525-528, 1986
30. Hack CE, Nuijens JH, Felt-Bersma RJF, et al: Elevated plasma levels of anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsis. Am J Med 86:20-26, 1989
31. Vincent JL, Moreno R, Takala J, et al: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med 22:707-710, 1996
32. Wanidworanun C, Strober W: Predominant role of tumor necrosis factor-a in human monocyte IL-10 synthesis. J Immunol 151:6853-6861, 1993
33. Van der Poll T, Jansen J, Levi M, et al: Regulation of interleukin 10 release by tumor necrosis factor in humans and chimpanzees. J Exp Med 180:1985-1988, 1994
34. Van der Poll T, Coyle SM, Barbosa K, et al: Epinephrine inhibits tumor necrosis factor-a and potentiates interleukin 10 production during human endotoxemia. J Clin Invest 97:713-719, 1996